Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renal Anhydramnios Fetal Therapy (RAFT) Trial
NCT03101891Phase 1Completed
- Sponsor
- Johns Hopkins University
- Start
- Dec 2018
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial in Anhydramnios (2 arms), sponsored by Johns Hopkins University. Primary endpoint: Neonates Surviving to >= 14 Days and Placement of Dialysis Access After Serial Amnioinfusions up to 3 weeks. Started Dec 2018; status: completed.
02
Conditions
Anhydramnios
Beyond the preview
Go deeper on NCT03101891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03101891.